In addition to oncogenic signaling mechanisms, NOS2-derived NO can also affect and tune anabolic and catabolic metabolism, including sugar, fatty acid, and amino acid metabolism, which are now considered as novel areas of cancer treatment research for the most clinically challenging cancers. The gene discussed is NOS2; the disease is cancer.